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Abstract As research into various aging-associated neuro-
degenerative disorders reveals their immense pathophysio-
logical complexity, the focus is currently shifting from
studying changes in an advanced disease state to investiga-
tions involving pre-symptomatic periods, possible aberrations
in early life, and even abnormalities in brain development.
Recent studies on the etiology of schizophrenia and autism
spectrum disorders revealed a profound impact of neurodeve-
lopmental disturbances on disease predisposition, onset and
progression. Here, we discuss how a prenatal immune chal-
lenge can affect the developing brain—with a selective focus
on the impact on microglia, the brain’s immune cells—and the
implications for brain aging and its associated risk of devel-
oping Alzheimer’s disease.
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Microglia in development
The immune system has developed to ensure cells of the innate
immune system reside in all organs of the body. The brain, far
from being a completely immune-privileged site, as thought
earlier, possesses its own immune cells (Ransohoff and Perry
2009). These are the microglia, and are the only cells in the
central nervous system (CNS) that do not originate from the
neuroectoderm (Allen and Barres 2009), but belong to the
myeloid lineage. After some debate about how these cells
populate the CNS– either via entering the developing brain
from peripheral circulation as monocytes followed by differen-
tiation (Perry et al. 1985), or multiplying from intraparenchymal
precursors that existed before the development of the vascula-
ture (Alliot et al. 1999), recent studies provided supporting
evidence that microglia derive from macrophages that originate
from the yolk-sac and then colonize the brain (Herbomel et al.
2001; Ginhoux et al. 2010). Still, what percentage of microglia
in the adult pool are remnants from these developmental pre-
cursors is unknown. While the predominant view is that micro-
glia are long-lived cells that are not often replenished from the
periphery, different studies have shown that, under certain con-
ditions, peripheral bone-marrow derived mononuclear phago-
cytes (BMDPs) can integrate into the CNS (Priller et al. 2001;
Massengale et al. 2005; Prinz and Mildner 2011). Moreover,
differential expression of certain markers, for instance, Hoxb8,
seem to indicate that at least two different microglial popula-
tions exist in the adult mouse brain (Chen et al. 2011), which
may have different implications for their function.
Once the microglia colonize the brain, several studies (Pont-
Lezica et al. 2011) have shown that contrary to being randomly
and evenly distributed throughout the brain, these cells appear
to concentrate specifically at certain locations, either being
associated with apoptotic neurons and radial glial cells, for
example, or being excluded from others, like the lens and
photoreceptor layer of the retina. The distribution of microglial
cells in the brain show region-specific differences with highest
density in the hippocampus, basal ganglia, olfactory telence-
phelon and substantia nigra, followed by cerebral cortex, tha-
lamus and hypothalamus, and lowest density in cerebellum
brain stem areas, and myelinated fibre tracts (Lawson et al.
1990; Lawson et al. 1993). Moreover, there even seems to be a
variation in where the majority of the morphologically distinct
microglia generally reside. Those with the shortest processes
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are found in the circumventricular regions, while the most
ramified microglia are found in the grey matter (Lawson et
al. 1990). This region-specific density, which varies around
five-fold, as well as the differences in morphology, appears to
be closely linked to the vast number of functions performed by
microglia.
During development, they play significant roles in the
formation of a healthy working environment in the CNS,
and accomplish this in various ways. First, microglia are
found in close association with cells undergoing developmen-
tal cell death, and have been shown to be capable of phag-
ocytosing apoptotic neurons (Peri and Nusslein-Volhard
2008). They have also been shown to control which cells
undergo apoptosis, via NGF signaling or triggering oxidative
stress (Frade and Barde 1998; Wakselman et al. 2008). Large
microglial populations have also been discovered free of
apoptotic cells, and these are thought to have other functions.
Those in close association with the developing vasculature
have been suggested to play a key role in angiogenesis, as
evidenced by the underdeveloped vascular system in mice
lacking microglia (Rymo et al. 2011). Others are associated
with developing axon tracts throughout the brain (Herbomel et
al. 2001), at the right time to influence neurite development
and axon remodeling, as well as synaptic pruning in develop-
ment (Paolicelli et al. 2011). Microglia have been shown to
contain large inclusions that often resemble axon terminals
and even spines (Tremblay 2012), and could contribute to
experience-dependent remodeling of synapses and developing
circuits. In line, members of the complement system, often
derived from microglia, have also been shown to be involved
in synapse elimination (Stevens et al. 2007). Recent research
also showed that mice lacking CX3CR1 (a microglia-specific
chemokine receptor) show significant impairments in synaptic
development as compared to wild-type littermates (for recent
review, Ransohoff and Perry 2009).
Microglia functions in the adult brain
The close and tightly regulated interaction between microglia
and neurons during brain development is maintained in the
adult brain. This has been highlighted by several studies
recently summarized by Trembay and colleagues (2011), in-
dicating that microglia are actively involved in the remodeling
of the perisynaptic environment and fine-tuning of neuronal
activity, likely also involving feedback signals provided by the
neurons to modulate the state of activity in microglia (Trem-
blay et al. 2011). This bidirectional communication is
achieved through interactions between cell-surface receptors
and cell-surface-bound ligands (i.e. CD200-CD200 recep-
tors), or at a distance after the generation of diffusible ligands,
as well as via neurotransmission-associated inhibition involv-
ing dopamine and noradrenaline and their respective receptors
(for recent review, Ransohoff and Cardona 2010). In turn,
through the release of a multitude of soluble factors including
neurotrophic factors chemokines, cytokines, microglia not
only perform classical glia functions, but also accomplish a
crucial immune function by surveillance of the brain for
damage infection, and engulfing infectious agents, dead cells
and debris (Streit 2006; Streit and Xue 2009).
At least two distinct configurations have been observed—
highly branched with long, fine processes, or rounded and
amoeboid. The former were considered to be “resting micro-
glia” that occur in a healthy, undisturbed CNS. This term later
proved to be a misnomer, since these cells were shown to be
highly dynamic, forming networks with their processes, while
their soma remain more or less stationary, that probe and test
the entire brain in a matter of a few hours (Nimmerjahn et al.
2005; Schlegelmilch et al. 2011; Wirenfeldt et al. 2011). The
onus is to designate these microglia more appropriately as
“surveying microglia” (Hanisch and Kettenmann 2007;
Marin-Teva et al. 2012). The amoeboid cells are indeed more
active in the immune sense, with the surveying glia transform-
ing to this phenotype, possessing upregulated antigen present-
ing molecules, when phagocytosis is required. This rapid
conversion to the amoeboid form is termed “activation of
microglia” and can be triggered by a variety of stimuli, ranging
from infection and trauma to ischemia or any disturbance in the
normal functioning of the brain (Kettenmann et al. 2011). The
abrupt response to neuronal injury could also be related to a
disrupted cell-cell contact and the concomitant loss of neuron-
mediated inhibition of microglia (for recent review, Ransohoff
and Cardona 2010). Whether these properties also relate to the
observed differences in the basal activation state of microglia
in white versus grey matter (Carson et al. 2007) remains to be
determined. However, it is conceivable that these functional
differences are linked to the expression profile of cell surface
markers, through which microglia are not only able to control
distinct population of neurons but also modulate a variety of
cellular and immune functions (for recent review, Lynch
2009). For instance, microglia can promote the infiltration of
circulating cells into the CNS (upregulation of CD11b, an
integrin family member which pairs with CD18 to form the
complement receptor 3), can be non-phagocytic and produce
proinflammatory molecules (CD40), or be phagocytic and
motile (MHCII), as shown for the highly effective clearance
of apoptotic neurons. In the adult brain, microglia are respon-
sible for all apoptotic debris, including the majority of new
born neurons (Sierra et al. 2010; Graeber and Streit 2010).
Based on morphology, it is thus possible to differentiate
microglia into different states including amoeboid (surveil-
ling) and ramified (activated) forms. A third potential state
has recently been hypothesized, by postulating that micro-
glia can devolve from their “surveying” state into an
“alerted” one, before becoming fully activated. This resem-
bles the process of priming of macrophages in the periphery,
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where activation occurs in two steps—priming, followed by
triggering (Dilger and Johnson 2008). A “primed” micro-
glial cell would thus react to a greater degree than a non-
primed one. In line with these hypothesis, once activated,
microglia tend not to return all the way to their “surveying”
state, thereby eliciting elevated responses to the next stim-
ulus (Schwartz et al. 2006). Microglia differ, however, from
peripheral immune cells in their preference for humoral
responses rather than eliciting the classical cytotoxic
responses, which involves the ingestion of antigens, exiting
the tissue and entering the draining lymph nodes, where
stimulation of naive T cells occurs. This happens perforce
due to the nature of the CNS environment—where the
neurons cannot regenerate as easily as cells in the periphery,
and collateral damage cannot be repaired.
Microglia in disease and aging
Several diseases, not only those of the CNS, appear to
impact on microglial activity and function. Infectious dis-
eases of the CNS (Mariani and Kielian 2009), conditions of
neuropathic pain (Ji and Suter 2007), even air pollution
(Block and Calderon-Garciduenas 2009) can create environ-
ments where microglia become highly activated, and after a
point, cannot protect the CNS any more. Looking at two
neurodegenerative diseases—multiple sclerosis (MS) and
traumatic spinal cord injury (SCI)—the role of microglia
in repairing the damage is highlighted. In cases of MS or
other demyelinating conditions, it has been shown that there
exists a subset of microglia at the site of demyelination that
can recruit oligodendrocyte precursor cells and phagocytose
damaged neurons (Olah et al. 2011). In SCI, cells of the
myeloid origin have been shown to play a role in intraspinal
trafficking past the injury (Hawthorne and Popovich 2011).
Beyond diseases, aging also represents a critical “primer” of
microglia activity, and is also accompanied by microglial
dystrophy and degeneration, a feature that appears to be ac-
companied by diminution of microglial neuroprotective func-
tions and hypothesized to significantly contribute to
neurodegenerative changes characteristic of AD (Streit 2004).
A combination of microglia senescence on one side and
priming-related hyperactivity on the other side is therefore
expected to have a detrimental influence on neuronal health.
This represents a highly relevant theory regarding AD patho-
genesis because it integrates aging as the most important risk
factor of this progressive neurodegenerative disease. However,
the molecular mechanisms underlying aging-associated micro-
glia dysfunction are largely unknown. Besides a decline in
proteasome activity and other aging-associated impairments
in protein homeostasis (Stolzing and Grune 2003), limited
information is available regarding the lifespan of microglia
(Streit 2006). It has been shown that nerve injury induces—
beside recruitment of bone marrow-derived precursors that can
infiltrate the brain—a burst in mitotic activity and a wave of
proliferation that is followed by apoptotic cell death of micro-
glia (Graeber et al. 1988; Gehrmann and Banati 1995; Lass-
mann et al. 1995). This represents an essential defense and
wound healing mechanism shown to be maintained in aged
rodents (Conde and Streit 2006) and suggested to be required
to keep the number of these endogenous immune defenders of
the CNS constant. It is conceivable, therefore, that repetitive
exposures to brain injury and inflammation induces replicative
senescence, eventual loss of mitotic activity and degeneration
of microglia during aging. Evidence for this hypothesis has
been provided by in vitro findings showing that microglia
stimulation by mitogens induces telomere shortening (Flanary
and Streit 2004). Recent data also showed that interferon-γ
exposure is sufficient to trigger activation-induced microglia
cell death (Yun et al. 2011), in line with postmortem inves-
tigations of AD patients showing caspase activity in plaque-
associated microglia in AD (Yang et al. 1998).
Specifically with respect to AD, the significance between
the association of microglia with amyloid plaques has long
been debated. Several studies have looked at the possibility
of using the phagocytic ability of microglia therapeutically
to clear the plaques, but largely, this doesn’t seem to have
the desired results on cognition. It has further been observed
that plaque-associated microglia still possess their processes
at the interface, and are capable of phagocytosing Aβ pep-
tides (Bolmont et al. 2008). However, it has also been
demonstrated that microglia show an age-dependent reduc-
tion in their ability to clear Aβ peptides, despite preserva-
tion of functional phagocytic activity and even adherence to
Aβ plaques (Floden and Combs 2011), underscoring the
importance of aging for microglial health and activity.
Prenatal PolyI:C model of accelerated aging
Interestingly, degeneration of microglia has also been
reported in neurological disorders without major neurode-
generative changes, such as schizophrenia, (Wierzba-Bobro-
wicz et al. 2004), or associations with aging. Besides genetic
risk factors, maternal infection during pregnancy represents
one of the currently most extensively studied risk factor in
experimental schizophrenia research. This is based on a
large body of epidemiological data that has provided com-
pelling evidence for enhanced risk of schizophrenia follow-
ing prenatal exposure to infection with various viral or
bacterial pathogens, or genital and/or reproductive infec-
tions (Brown et al. 2006; Patterson 2007; Boksa 2008). This
data indicates that the early inflammatory insult not only
strongly affects the developing nervous system and predis-
poses the offspring to psychosis-related behavioural abnor-
malities in adulthood, but likely also critically influences the
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proliferation, maturation and function of the developing
immune system. The findings of significantly elevated lev-
els of degenerating microglia seen in frontal and temporal
cortices of schizophrenia patients compared to healthy sub-
jects (Wierzba-Bobrowicz et al. 2004) indeed supports the
hypothesis that early prenatal infection-induced expression
of pro-inflammatory cytokines and other mediators of the
innate immunity might reduce the proliferative capacity of
microglia and hence reduce their lifespan.
To investigate the impact of a prenatal infection on brain
and immune system development, we established a mouse
model that is based on the critical contribution of the gesta-
tional stage during which the maternal immune challenge
occurs. It builds on findings reported by other groups that
demonstrated a wide spectrum of behavioural, neuroana-
tomical, and neurochemical changes following exposure to
viral or bacterial pathogens in rats and mice that mimicked
critical phenotypic symptoms of schizophrenia (for recent
review, Meyer et al. 2009). Based on the highly comparable
phenotype induced by the various types of pathogens we
reasoned that the downstream effects, i.e. the production of
pro-inflammatory cytokines might be the critical common
denominator of the behavioural and neurochemical changes
described. To test this, we employed a viral mimic,
Polyriboinosinic-polyribocytidilic acid (PolyI:C), a double-
stranded RNA shown to bind to Toll-like receptor 3 (TLR3),
leading to activation of nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) and production of
pro-inflammatory cytokines such as TNF-α, IL-6 and IL-12
(Alexopoulou et al. 2001; Okun et al. 2011). Given the
critical processes during the development of the brain and
its resident immune cells, we decided to contrast early, mid-
and late-gestational stages. We hypothesize that the devel-
opmental stage critically determines the phenotype of the
adult offspring, allowing us to test whether prenatal infec-
tions may—in addition to the widely accepted role in the
etiology of neuropsychiatric diseases—also contribute to
brain aging and neurodegenerative diseases.
Our first findings indeed confirmed that the time of mater-
nal immune challenge critically determines the patterns of
fetal immunological, juvenile neurochemical, as well as adult
behavioural abnormalities displayed by the offspring (Meyer
et al. 2006). While the PolyI:C challenge during early-
gestation (gestational day 6, GD6) resulted in a high incidence
of abortion, a viral-like infection during mid-gestation (GD9)
confirmed the precipitation of psychosis-related symptoms in
the adult offspring, in line with previous findings by other
groups (Borrell et al. 2002; Shi et al. 2003; Zuckerman et al.
2003; Zuckerman and Weiner 2005; Ozawa et al. 2006;
Romero et al. 2007). A late-gestational (GD17) immune chal-
lenge resulted in a behavioural phenotype characterized by
cognitive impairments, elevation of fetal IL6, IL10, and
TNFα, enhanced apoptosis in the dentate gyrus, as well as a
decline in Reelin-positive cells in juvenile brains (Fig. 1). We
showed for the first time that the fetal brain can directly
contribute to the specific changes in inflammatory cytokine
protein levels after late-gestational but not mid-gestational
immune challenge, suggesting a close correlation between
acute immunological modulators and histopathological
changes in the juvenile offspring. We also reported that the
mid- and late-gestational infections had a differential impact
on the developing neurotransmitter systems (Meyer et al.
2008). Using immunohistochemical approaches and unbiased
stereological evaluations, we provided first evidence that a
prenatal immune challenge around mid-gestation has a stron-
ger impact on the prefrontal dopamine receptor D1 expression
as compared to the treatment effect at GD17. These neuro-
chemical alterations were accompanied with behavioural ab-
normalities with relevance to positive symptom clusters
characteristic of schizophrenia. On the other hand, an in utero
immune challenge at GD17 preferentially affected the expres-
sion levels of the hippocampal NR1 subunit of the NMDA
receptor as compared to GD9 and control treatments, which
were paralleled by impairments in working memory perfor-
mance. These studies revealed also that a prenatal immune
challenge during late gestation resulted in acceleration of
aging, as indicated by the earlier formation of Reelin-
positive extracellular amyloid-like deposits, a neuropatholog-
ical feature detected in the hippocampal formation in several
Fig. 1 Schematic representation of the critical differences resulting
from a prenatal immune challenge at different time periods in gestation
Fig. 2 Glial cells in prenatal astrocyte cultures undergo morphological
changes upon immune stimulation. a–b, Immunofluorescence staining
of astrocytes (mouse anti-GFAP, 1:5000, Dako, Z334; green) and
microglia (rabbit anti-Iba1, 1:4000, Wako Nr. 019–19741; red) in
astrocyte cultures prepared from E18 rats that were exposed at day 3
to PolyI:C (200 μg/ml, P9582, Sigma), vehicle (0.9 % pyrogen-free
NaCl, B. Braun, 534534), or left undisturbed. The nuclei were counter-
stained with DAPI (Thermo Scientific Pierce, Switzerland; blue).
Triple-immunofluorescence labelings of the paraformaldehyde-fixed
cells (at day 7 in vitro) were visualized by confocal microscopy using
sequential acquisition of separate channels. Z-stacks of consecutive
optical sections were summed and projected in the z dimension (max-
imal intensity) and merged using the image analysis software Imaris
(Bitplane, Zurich, Switzerland) for visual display. Note that the im-
mune challenge with PolyI:C altered the ramified phenotype found in
untreated and NaCl-treated cultures into an amoeboid-like appearance
indicative of activated microglia. Scale bar: a: 50 μm, b: high magni-
fication image: 15 μm

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species that is accompanied by a reduction in Reelin-
expressing neurons (Knuesel et al. 2009; Knuesel 2010). Both
neuropathological alterations significantly correlated with
hippocampus-dependent episodic-like memory deficits
(Knuesel et al. 2009). We found that healthy and cognitively
normal subjects were able to sufficiently clear and degrade
these deposits, whereas cognitively impaired aged mice failed
to do so. Our results showed for the first time that prenatal
exposure to infection during late embryonic developmental
stages is not only an important factor in the segregation of
certain behavioural symptom clusters with relevance for neu-
ropsychiatric disorders but does also represent a critical driv-
ing force of aging-related neuropathological processes.
Effects of PolyI:C in vitro and in vivo on microglia
These observations indicated that the effect of PolyI:C on
microglia and astrocytes could be highly relevant for such
neuropathology. Supporting this view, our studies with pri-
mary cultures of these cells revealed that PolyI:C could
trigger the morphological changes underlying the transfor-
mation of microglia into their activated state, as compared to
the ramified morphology of the untreated, or saline treated,
surveying microglia, but not changes in astrocyte morphol-
ogy (Fig. 2; Vogel et al., unpublished data). The implication
here is that PolyI:C induces a strong and distinct immune
response through the TLR3 found on microglia, but saline, a
likely stressor, activates different cellular pathways, leading
only to a mild or non-selective immune response.
The mRNA of different TLRs has previously been shown
to be enriched in the vicinity of amyloid plaques (Frank et
al. 2009), likely reflecting their localization on microglia.
Our own observations in aged prenatally immune-
challenged mice reveal a striking overlap between micro-
glial and TLR3 immunoreactivity (Vogel et al., unpublished
data). Besides establishing a chronic adverse neuronal envi-
ronment, the prenatal immune challenge might prime micro-
glia and thereby alter their ability to react to different stimuli
and create an innate memory allowing a faster and exagger-
ated response upon a second challenge; changes highly
comparable to mechanisms in the adaptive immune system.
The strong glial response may then have devastating effects
on surrounding neurons resulting in demyelination and ap-
optosis due to release of ROS.
New perspectives and future outlooks
Having seen how delicately balanced the immune system is in
the CNS, it becomes more evident that inflammation at critical
points during development can have a serious and long-lasting
impact on microglial function, and thus, on how the brain
ages. Studyingmicroglia during development and understand-
ing the different aspects of their priming and activation could
provide insights to disorders that set in much later in life, like
AD. Everyone’s goal of healthy aging seems thus to depend
more on proper developmental processes than so far
anticipated.
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